Khiron Life Sciences Corp (CVE:KHRN) President on Potential of Brazilian Medical Market

Khiron Life Sciences Corp (CVE:KHRN) (OTCMKTS:KHRNF) (FRA:4KH) President Chris Naprawa is thrilled the company’s stock has been on fire in 2019 and believes investors are realizing the global opportunity cannabis offers. Naprawa discusses the importance of Brazil, noting the country is potentially the largest medical cannabis market in the world. Khiron’s deal with NettaGro should be completed soon and allows the company to prepare for the Brazilian market in advance of legalization. Naprawa indicates that Khiron’s clinical business is still driving revenue for the company while its Kuida-branded product sales continue to grow since launching in November. Naprawa emphasizes the importance of the cosmeceutical space. Khiron is taking part in the largest cosmetics conference in the world in Bologna, Italy and will be one of the few cannabis companies in attendance.


Check out our website:



SUBSCRIBE to our YouTube:

SUBSCRIBE to our 2nd YouTube Channel – Midas Letter Clips:

SUBSCRIBE to our Newsletter:

Download Our Podcast on iTunes:


Follow Us on Twitter:

Like Us on Instagram:

Like Us on Facebook:




Leave a Reply

Your email address will not be published. Required fields are marked *